The Federalist Society

Association for Molecular Pathology v. Myriad Genetics, Inc. - Post-Decision SCOTUScast

SCOTUScast 6-19-13 featuring Gregory Dolin

June 19, 2013

Gregory Dolin

To listen, please right click on the audio file you wish to hear and then select "Save Link As..." or "Save Target As..." After you save the audio file to your computer, you can then listen to it in your audio player of choice.

Association for Molecular Pathology v. Myriad Genetics, Inc - Post-Decision SCOTUScast - MP3
Running Time: 00:11:49 

Gregory DolinOn June 13, 2013, the Supreme Court announced its decision in Association for Molecular Pathology v. Myriad Genetics, Inc.  The issue in this case was whether human genes are patentable. 

In an opinion delivered by Justice Thomas, the Court held by a vote of 9-0 that a naturally occurring DNA segment is not patentable merely because it has been isolated, but that “complementary” DNA, which is synthetic and does not occur in nature, is patent-eligible.  Justice Scalia filed an opinion concurring in part and in the judgment.

To discuss the case, we have Gregory Dolin, who is Associate Professor and Co-Director of the Center for Medicine and Law at the University of Baltimore School of Law.

[Return to the SCOTUScast menu] 

Related Links

Association for Molecular Pathology v. Myriad Genetics - Post-Argument SCOTUScast
Opinion - June 13, 2013 (PDF)
Oral Argument Transcript - April 15, 2013 (PDF)


The Federalist Society